CARD11: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
== CARD11 == | |||
CARD11 | |||
[[File:CARD11.png|thumb|right|Diagram of CARD11 protein structure]] | |||
'''CARD11''' (Caspase Recruitment Domain Family Member 11) is a protein encoded by the '''CARD11''' gene in humans. It is a member of the [[caspase recruitment domain]] (CARD) family of proteins, which are involved in the regulation of [[apoptosis]] and [[immune response]]. CARD11 plays a crucial role in the activation of [[NF-_B]] signaling pathways, which are essential for [[lymphocyte]] activation, proliferation, and survival. | |||
== Structure == | |||
CARD11 is characterized by the presence of a CARD domain, which is a protein interaction module that mediates the assembly of signaling complexes. The protein also contains a coiled-coil domain, a [[PDZ domain]], and a [[MAGUK]] domain, which are important for its function in signal transduction. | |||
== Function == | == Function == | ||
CARD11 | |||
CARD11 is primarily expressed in [[lymphoid tissue]] and is a critical component of the [[B-cell receptor]] (BCR) and [[T-cell receptor]] (TCR) signaling pathways. Upon antigen recognition, CARD11 undergoes a conformational change that allows it to interact with other signaling molecules, leading to the activation of the [[IKK complex]] and subsequent activation of NF-_B. | |||
== Clinical Significance == | == Clinical Significance == | ||
Mutations in the CARD11 gene have been associated with various [[immunodeficiency]] disorders and [[lymphoproliferative disease]]s. Gain-of-function mutations can lead to constitutive activation of NF-_B, contributing to the development of [[B-cell lymphoma]]s. Conversely, loss-of-function mutations can result in impaired immune responses, leading to conditions such as [[severe combined immunodeficiency]] (SCID). | |||
== Research == | == Research == | ||
[[Category: | Ongoing research is focused on understanding the precise molecular mechanisms by which CARD11 regulates NF-_B signaling and its role in immune system disorders. Targeting CARD11 and its associated pathways is being explored as a potential therapeutic strategy for treating certain types of cancer and autoimmune diseases. | ||
== Related pages == | |||
* [[NF-_B]] | |||
* [[Apoptosis]] | |||
* [[B-cell receptor]] | |||
* [[T-cell receptor]] | |||
* [[Immunodeficiency]] | |||
[[Category:Proteins]] | |||
[[Category:Immune system]] | [[Category:Immune system]] | ||
Latest revision as of 04:03, 13 February 2025
CARD11[edit]

CARD11 (Caspase Recruitment Domain Family Member 11) is a protein encoded by the CARD11 gene in humans. It is a member of the caspase recruitment domain (CARD) family of proteins, which are involved in the regulation of apoptosis and immune response. CARD11 plays a crucial role in the activation of NF-_B signaling pathways, which are essential for lymphocyte activation, proliferation, and survival.
Structure[edit]
CARD11 is characterized by the presence of a CARD domain, which is a protein interaction module that mediates the assembly of signaling complexes. The protein also contains a coiled-coil domain, a PDZ domain, and a MAGUK domain, which are important for its function in signal transduction.
Function[edit]
CARD11 is primarily expressed in lymphoid tissue and is a critical component of the B-cell receptor (BCR) and T-cell receptor (TCR) signaling pathways. Upon antigen recognition, CARD11 undergoes a conformational change that allows it to interact with other signaling molecules, leading to the activation of the IKK complex and subsequent activation of NF-_B.
Clinical Significance[edit]
Mutations in the CARD11 gene have been associated with various immunodeficiency disorders and lymphoproliferative diseases. Gain-of-function mutations can lead to constitutive activation of NF-_B, contributing to the development of B-cell lymphomas. Conversely, loss-of-function mutations can result in impaired immune responses, leading to conditions such as severe combined immunodeficiency (SCID).
Research[edit]
Ongoing research is focused on understanding the precise molecular mechanisms by which CARD11 regulates NF-_B signaling and its role in immune system disorders. Targeting CARD11 and its associated pathways is being explored as a potential therapeutic strategy for treating certain types of cancer and autoimmune diseases.